<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> has been implicated in the development of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, but its role in the pathogenesis of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> is unclear </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the association between C-reactive protein (CRP) levels and the development of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in men </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Serum CRP concentrations and factors related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> were determined in middle-aged Finnish men who participated in a population-based cohort study and were free of <z:mp ids='MP_0002055'>diabetes</z:mp> at baseline </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: At the 11-year follow-up, 143 of 680 men had developed the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> as defined by the National Cholesterol Education Program (NCEP) and 103 of 598 men had developed the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> as defined by the World Health Organization (WHO) </plain></SENT>
<SENT sid="4" pm="."><plain>Our analyses excluded men with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> by the respective definition at baseline </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo>, 78 of 762 men developed <z:mp ids='MP_0002055'>diabetes</z:mp> over the same period </plain></SENT>
<SENT sid="6" pm="."><plain>Men with CRP concentrations &gt; or =3 mg/l had a several-fold higher age-adjusted risk of developing the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (NCEP definition: odds ratio [OR]=3.2, 95% CI 1.9-5.5; WHO definition: OR=3.4, 95% CI 2.0-6.1) or <z:mp ids='MP_0002055'>diabetes</z:mp> (OR=4.1, 95% CI 2.1-8.0) than men whose CRP levels were &lt;1.0 mg/l </plain></SENT>
<SENT sid="7" pm="."><plain>Even after further adjustment for potentially confounding lifestyle factors and factors related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> (OR=2.3, 95% CI 1.0-5.1) was still increased in men with CRP concentrations &gt; or =3 mg/l, but the association with the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> was no longer significant </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: Low-grade <z:mp ids='MP_0001845'>inflammation</z:mp> may increase the risk of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> in middle-aged men, but some of the risk is mediated through <z:hpo ids='HP_0001513'>obesity</z:hpo> and factors related to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
</text></document>